Ventilator Associated Pneumonia (VAP) Therapeutics Market Report

China Ventilator Associated Pneumonia (VAP) Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Oct 06, 2023
  • PAGES：143
  • REPORT CODE：GMM1831997
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Ventilator Associated Pneumonia (VAP) Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Bayer AG

    • Achaogen Inc

    • Zavante Therapeutics Inc

    • Lakewood-Amedex Inc

    • Dong-A Socio Holdings Co Ltd

    • Wockhardt Ltd

    • Adenium Biotech ApS

    • Destiny Pharma Ltd

    • Polyphor Ltd

    • Shionogi & Co Ltd

    • Aridis Pharmaceuticals LLC

    • Theravance Biopharma Inc

    • Motif Bio Plc

    • AstraZeneca Plc

    • Merck & Co Inc

    • Meiji Seika Pharma Co Ltd

    • The Medicines Company

    • Nabriva Therapeutics AG

    By Type:

    • Prevention

    • Physiotherapy

    • Immunity Therapy

    By Application:

    • Diagnostic Centers

    • Hospitals

    • Ambulatory Surgical Center

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Overview 2018-2029

    • 1.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Industry Development Overview

    • 1.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Industry Development History

    • 1.3 China Ventilator Associated Pneumonia (VAP) Therapeutics Industry Market Size (2018-2029)

    • 1.4 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume, Production Value and Growth Rate of Prevention (2018-2029)

      • 1.4.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume, Production Value and Growth Rate of Physiotherapy (2018-2029)

      • 1.4.3 China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume, Production Value and Growth Rate of Immunity Therapy (2018-2029)

    • 1.5 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume, Sales Value and Growth Rate of Diagnostic Centers (2018-2029)

      • 1.5.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.3 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Center (2018-2029)

    • 1.6 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Analysis by Region

      • 1.6.1 North China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Ventilator Associated Pneumonia (VAP) Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Ventilator Associated Pneumonia (VAP) Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Ventilator Associated Pneumonia (VAP) Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Ventilator Associated Pneumonia (VAP) Therapeutics Industry Development

    Chapter 3 Ventilator Associated Pneumonia (VAP) TherapeuticsIndustry Chain Analysis

    • 3.1 Ventilator Associated Pneumonia (VAP) Therapeutics Industry Chain

    • 3.2 Ventilator Associated Pneumonia (VAP) Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Ventilator Associated Pneumonia (VAP) Therapeutics Market

    • 3.3 Ventilator Associated Pneumonia (VAP) Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Ventilator Associated Pneumonia (VAP) Therapeutics Market

    Chapter 4 China Ventilator Associated Pneumonia (VAP) Therapeutics Market, by Type

    • 4.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Ventilator Associated Pneumonia (VAP) Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume and Growth Rate of Prevention

      • 4.5.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume and Growth Rate of Physiotherapy

      • 4.5.3 China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume and Growth Rate of Immunity Therapy

    Chapter 5 China Ventilator Associated Pneumonia (VAP) Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Ventilator Associated Pneumonia (VAP) Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate of Diagnostic Centers

      • 5.5.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate of Hospitals

      • 5.5.3 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate of Ambulatory Surgical Center

    Chapter 6 China Ventilator Associated Pneumonia (VAP) Therapeutics Market, by Region

    • 6.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume and Production Value, by Region

    • 6.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China Ventilator Associated Pneumonia (VAP) Therapeutics Market Analysis

    • 7.1 North China Ventilator Associated Pneumonia (VAP) Therapeutics Market, by Type

    • 7.2 North China Ventilator Associated Pneumonia (VAP) Therapeutics Market, by Application

    Chapter 8 Central China Ventilator Associated Pneumonia (VAP) Therapeutics Market Analysis

    • 8.1 Central China Ventilator Associated Pneumonia (VAP) Therapeutics Market, by Type

    • 8.2 Central China Ventilator Associated Pneumonia (VAP) Therapeutics Market, by Application

    Chapter 9 South China Ventilator Associated Pneumonia (VAP) Therapeutics Market Analysis

    • 9.1 South China Ventilator Associated Pneumonia (VAP) Therapeutics Market, by Type

    • 9.2 South China Ventilator Associated Pneumonia (VAP) Therapeutics Market, by Application

    Chapter 10 East China Ventilator Associated Pneumonia (VAP) Therapeutics Market Analysis

    • 10.1 East China Ventilator Associated Pneumonia (VAP) Therapeutics Market, by Type

    • 10.2 East China Ventilator Associated Pneumonia (VAP) Therapeutics Market, by Application

    Chapter 11 Northeast China Ventilator Associated Pneumonia (VAP) Therapeutics Market Analysis

    • 11.1 Northeast China Ventilator Associated Pneumonia (VAP) Therapeutics Market, by Type

    • 11.2 Northeast China Ventilator Associated Pneumonia (VAP) Therapeutics Market, by Application

    Chapter 12 Southwest China Ventilator Associated Pneumonia (VAP) Therapeutics Market Analysis

    • 12.1 Southwest China Ventilator Associated Pneumonia (VAP) Therapeutics Market, by Type

    • 12.2 Southwest China Ventilator Associated Pneumonia (VAP) Therapeutics Market, by Application

    Chapter 13 Northwest China Ventilator Associated Pneumonia (VAP) Therapeutics Market Analysis

    • 13.1 Northwest China Ventilator Associated Pneumonia (VAP) Therapeutics Market, by Type

    • 13.2 Northwest China Ventilator Associated Pneumonia (VAP) Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Bayer AG

        • 14.1.1 Bayer AG Company Profile

        • 14.1.2 Bayer AG Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Achaogen Inc

        • 14.2.1 Achaogen Inc Company Profile

        • 14.2.2 Achaogen Inc Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Zavante Therapeutics Inc

        • 14.3.1 Zavante Therapeutics Inc Company Profile

        • 14.3.2 Zavante Therapeutics Inc Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Lakewood-Amedex Inc

        • 14.4.1 Lakewood-Amedex Inc Company Profile

        • 14.4.2 Lakewood-Amedex Inc Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Dong-A Socio Holdings Co Ltd

        • 14.5.1 Dong-A Socio Holdings Co Ltd Company Profile

        • 14.5.2 Dong-A Socio Holdings Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Wockhardt Ltd

        • 14.6.1 Wockhardt Ltd Company Profile

        • 14.6.2 Wockhardt Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Adenium Biotech ApS

        • 14.7.1 Adenium Biotech ApS Company Profile

        • 14.7.2 Adenium Biotech ApS Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Destiny Pharma Ltd

        • 14.8.1 Destiny Pharma Ltd Company Profile

        • 14.8.2 Destiny Pharma Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Polyphor Ltd

        • 14.9.1 Polyphor Ltd Company Profile

        • 14.9.2 Polyphor Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Shionogi & Co Ltd

        • 14.10.1 Shionogi & Co Ltd Company Profile

        • 14.10.2 Shionogi & Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Aridis Pharmaceuticals LLC

        • 14.11.1 Aridis Pharmaceuticals LLC Company Profile

        • 14.11.2 Aridis Pharmaceuticals LLC Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Theravance Biopharma Inc

        • 14.12.1 Theravance Biopharma Inc Company Profile

        • 14.12.2 Theravance Biopharma Inc Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Motif Bio Plc

        • 14.13.1 Motif Bio Plc Company Profile

        • 14.13.2 Motif Bio Plc Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 AstraZeneca Plc

        • 14.14.1 AstraZeneca Plc Company Profile

        • 14.14.2 AstraZeneca Plc Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Merck & Co Inc

        • 14.15.1 Merck & Co Inc Company Profile

        • 14.15.2 Merck & Co Inc Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Meiji Seika Pharma Co Ltd

        • 14.16.1 Meiji Seika Pharma Co Ltd Company Profile

        • 14.16.2 Meiji Seika Pharma Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 The Medicines Company

        • 14.17.1 The Medicines Company Company Profile

        • 14.17.2 The Medicines Company Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Nabriva Therapeutics AG

        • 14.18.1 Nabriva Therapeutics AG Company Profile

        • 14.18.2 Nabriva Therapeutics AG Ventilator Associated Pneumonia (VAP) Therapeutics Market Performance

        • 14.18.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Ventilator Associated Pneumonia (VAP) Therapeutics Industry Research Conclusions

    • 15.2 Ventilator Associated Pneumonia (VAP) Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Industry Market Size (2018-2029)

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume, Production Value and Growth Rate of Prevention (2018-2029)

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume, Production Value and Growth Rate of Physiotherapy (2018-2029)

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume, Production Value and Growth Rate of Immunity Therapy (2018-2029)

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume, Sales Value and Growth Rate of Diagnostic Centers (2018-2029)

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Center (2018-2029)

    • Figure North China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Ventilator Associated Pneumonia (VAP) Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Market Share by Type in 2018

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Market Share by Type in 2023

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume and Growth Rate of Prevention (2018-2023)

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume and Growth Rate of Physiotherapy (2018-2023)

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume and Growth Rate of Immunity Therapy (2018-2023)

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Market Share by Application in 2018

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Market Share by Application in 2023

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate of Diagnostic Centers (2018-2023)

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size and Growth Rate of Ambulatory Surgical Center (2018-2023)

    • Table China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume by Region (2018-2023)

    • Table China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume Share by Region (2018-2023)

    • Table China Ventilator Associated Pneumonia (VAP) Therapeutics Production Value by Region (2018-2023)

    • Table China Ventilator Associated Pneumonia (VAP) Therapeutics Production Value Share by Region (2018-2023)

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Production Value Share by Region (2018-2023)

    • Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume by Region (2018-2023)

    • Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Value by Region (2018-2023)

    • Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume by Type (2018-2023)

    • Table North China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume by Application (2018-2023)

    • Table North China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume by Type (2018-2023)

    • Table Central China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume by Type (2018-2023)

    • Table South China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume by Application (2018-2023)

    • Table South China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume by Type (2018-2023)

    • Table East China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume by Application (2018-2023)

    • Table East China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Ventilator Associated Pneumonia (VAP) Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Bayer AG Company Profile

    • Table Bayer AG Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Achaogen Inc Company Profile

    • Table Achaogen Inc Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Zavante Therapeutics Inc Company Profile

    • Table Zavante Therapeutics Inc Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Lakewood-Amedex Inc Company Profile

    • Table Lakewood-Amedex Inc Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Dong-A Socio Holdings Co Ltd Company Profile

    • Table Dong-A Socio Holdings Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Wockhardt Ltd Company Profile

    • Table Wockhardt Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Adenium Biotech ApS Company Profile

    • Table Adenium Biotech ApS Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Destiny Pharma Ltd Company Profile

    • Table Destiny Pharma Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Polyphor Ltd Company Profile

    • Table Polyphor Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Shionogi & Co Ltd Company Profile

    • Table Shionogi & Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Aridis Pharmaceuticals LLC Company Profile

    • Table Aridis Pharmaceuticals LLC Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Theravance Biopharma Inc Company Profile

    • Table Theravance Biopharma Inc Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Motif Bio Plc Company Profile

    • Table Motif Bio Plc Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Plc Company Profile

    • Table AstraZeneca Plc Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Merck & Co Inc Company Profile

    • Table Merck & Co Inc Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Meiji Seika Pharma Co Ltd Company Profile

    • Table Meiji Seika Pharma Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table The Medicines Company Company Profile

    • Table The Medicines Company Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Nabriva Therapeutics AG Company Profile

    • Table Nabriva Therapeutics AG Ventilator Associated Pneumonia (VAP) Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US